Ivan Marquez-Rodas (Ivan Márquez-Rodas, Ivan Marquez, I Márquez-Rodas, I Márquez Rodas, Iván Márquez-Rodas, Iván Márquez Rodas)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Prognostic Factors

Top Venues

The Journal of pathology

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey S Weber, Michele Del Vecchio, Mario Mandala, Helen J Gogas, Ana M Arance, Stephane Dalle, C Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion Sileni, Ivan Marquez-Rodas, Marcus O Butler, Anna Maria Di Giacomo, Luis de la Cruz Merino, Petr Arenberger, Victoria Atkinson, Andrew Hill, Leslie A Fecher, Michael Millward, Nikhil I Khushalani, Paola Queirolo, Georgina V Long, Maurice Lobo, Margarita Askelson, Paolo Antonio Ascierto, James M G Larkin
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Celia Barrio-Alonso, Alicia Nieto-Valle, Elena García-Martínez, Alba Gutiérrez-Seijo, Verónica Parra-Blanco, Ivan Marquez-Rodas, José Antonio Avilés-Izquierdo, Paloma Sánchez-Mateos, Rafael Samaniego
Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma. The Journal of pathology (2024)
Celia Barrio-Alonso, Alicia Nieto-Valle, Elena García-Martínez, Alba Gutiérrez-Seijo, Verónica Parra-Blanco, Ivan Marquez-Rodas, José Antonio Avilés-Izquierdo, Paloma Sánchez-Mateos, Rafael Samaniego
Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma. The Journal of pathology 262 (4) (2024)
Ana Martinez-Riaño, Laura Mosteo, Paula Molero-Glez, Ivan Marquez-Rodas, Ignacio Melero Bermejo
Double-stranded RNA to mimic viral infection for cancer immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ana Martinez-Riaño, Laura Mosteo, Paula Molero-Glez, Ivan Marquez-Rodas, Ignacio Melero Bermejo
Double-Stranded RNA to Mimic Viral Infection for Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Ivan Marquez-Rodas, Eva Muñoz Couselo, Juan F Rodríguez Moreno, Ana Mª Arance Fernández, Miguel Ángel Berciano Guerrero, Begoña Campos Balea, Luis de la Cruz Merino, Enrique Espinosa Arranz, Almudena García Castaño, Alfonso Berrocal Jaime
SEOM-GEM clinical guidelines for cutaneous melanoma (2023). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Celia Barrio-Alonso, Alicia Nieto-Valle, Elena García-Martínez, Alba Gutiérrez-Seijo, Verónica Parra-Blanco, Ivan Marquez-Rodas, José Antonio Avilés-Izquierdo, Paloma Sánchez-Mateos, Rafael Samaniego
Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma. The Journal of pathology 262 (4) (2024)
Celia Barrio-Alonso, Alicia Nieto-Valle, Elena García-Martínez, Alba Gutiérrez-Seijo, Verónica Parra-Blanco, Ivan Marquez-Rodas, José Antonio Avilés-Izquierdo, Paloma Sánchez-Mateos, Rafael Samaniego
Chemokine profiling of melanoma-macrophage crosstalk identifies CCL8 and CCL15 as prognostic factors in cutaneous melanoma. The Journal of pathology 262 (4) (2024)
Antonio Calles, Marta Arregui, Julia Suárez-González, María García-Martos, Ivan Marquez-Rodas, Rosa Álvarez, Miguel Martin
Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report. JCO precision oncology 7 (2023)
Eduardo Zatarain-Nicolás, Pilar Martin, Ivan Marquez-Rodas, Juan Virizuela, Ana Martín García, Cristina Mitroi, Juan Cosín Sales, Vivencio Barrios, Fátima Sánchez-Cabo, Francesco Lavarra, Javier De Castro Carpeño, Teresa López Fernández
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
James M G Larkin, Michele Del Vecchio, Mario Mandala, Helen J Gogas, Ana M Arance, Stéphane Dalle, Charles Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion Sileni, Ivan Marquez-Rodas, Marcus O Butler, Anna Maria Di Giacomo, Mark Ross Middleton, Jose Lutzky, Luis de la Cruz Merino, Petr Arenberger, Victoria Atkinson, Andrew G Hill, Leslie A Fecher, Michael Millward, Paul D Nathan, Nikhil I Khushalani, Paola Queirolo, Corey Ritchings, Maurice Lobo, Margarita Askelson, Hao Tang, Sonia Dolfi, Paolo Antonio Ascierto, Jeffrey S Weber
Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ana M Arance, Luis de la Cruz Merino, Teresa M Petrella, Rahima Jamal, Lars Ny, Ana Carneiro, Alfonso Berrocal, Ivan Marquez-Rodas, Anna Spreafico, Victoria Atkinson, Fernanda Costa Svedman, Andrew Mant, Muhammad A Khattak, Catalin Mihalcioiu, Sekwon Jang, C Lance Cowey, Alan D Smith, Natalyn Hawk, Ke Chen, Scott J Diede, Clemens Krepler, Georgina V Long
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Mario Mandala, James Larkin, Paolo Antonio Ascierto, Michele Del Vecchio, Helen J Gogas, C Lance Cowey, Ana Arance, Stéphane Dalle, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion-Sileni, Ivan Marquez-Rodas, Marcus O Butler, Anna Maria Di Giacomo, Jose Lutzky, Luis De La Cruz-Merino, Victoria Atkinson, Petr Arenberger, Andrew Hill, Leslie Fecher, Michael Millward, Nikhil I Khushalani, Veerle de Pril, Maurice Lobo, Jeffrey S Weber
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival. Journal for immunotherapy of cancer 9 (8) (2022)
Jyoti Chauhan, Sathyaraj Aasaithambi, Ivan Marquez-Rodas, Luigi Formisano, Sophie Papa, Nicolas Meyer, Andrea Forschner, Guy Faust, Mike Lau, Alexandros Sagkriotis
Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis. JMIR cancer 8 (2) (2022)
Jedd D Wolchok, Vanna Chiarion Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Lukasz Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O Butler, Andrew Hill, Ivan Marquez-Rodas, John B A G Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Celeste Lebbè, Grant A McArthur, Paolo Antonio Ascierto, Gregory A Daniels, Georgina V Long, Tuba Bas, Corey Ritchings, James M G Larkin, Frank Stephen Hodi
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Maria Gonzales Cao, Teresa Puertolas, Mar Riveiro, Eva Muñoz-Couselo, Carolina Ortiz, Roger Paredes, Daniel Podzamczer, Jose Luis Manzano, Jose Molto, Boris Revollo, Cristina Carrera, Lourdes Mateu, Sara Fancelli, Enrique Espinosa, Bonaventura Clotet, Javier Martinez-Picado, Pablo Cerezuela, Ainara Soria, Ivan Marquez-Rodas, Mario Mandala, Alfonso Berrocal, null null
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Journal for immunotherapy of cancer 9 (3) (2021)
Ivan Marquez-Rodas, Federico Longo, Maria E Rodríguez-Ruiz, Antonio Calles, Santiago Ponce-Aix, Maria Jove, Belén Rubio-Viqueira, Jose Luis Perez-Gracia, Ana Gómez-Rueda, Miguel Martín, Mariano Ponz-Sarvisé, Rosa Álvarez, Ainara Soria-Rivas, Enrique de Miguel, Rocío Ramos-Medina, Eduardo Castañon, Pablo Gajate, Cayetano Sempere Ortega, Elisabeth Jiménez-Aguilar, Maria Angela Aznar, Aitana Calvo, Pedro P López-Casas, Salvador Martín-Algarra, Miguel Martín, Dominique Tersago, Marisol Quintero, Ignacio Melero
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors. Science translational medicine 12 (565) (2021)
J A Avilés Izquierdo, I Molina López, P Sobrini Morillo, Ivan Marquez-Rodas, E Mercader Cidoncha
Utility of PET/CT in patients with stage I-III melanoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (8) (2019)
Ivan Marquez-Rodas, A Arance, A Berrocal, C L Larios, J Curto-García, I X Campos-Tapias, A B Blanca, S Martin-Algarra
A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in Spain. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (12) (2019)